| 摘要 |
Novel compounds of the formula I in which Y, T, W, R<1 >and R<2 >are as defined in Patent Claim (1), are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumours.
|
